SHL TELEMEDICINE N/ IL0010855885 /
2024-05-08 5:31:55 PM | Chg. -0.2000 | Volume | Bid5:40:00 PM | Ask5:40:00 PM | Market Capitalization | Dividend Y. | P/E Ratio |
---|---|---|---|---|---|---|---|
3.7000CHF | -5.13% | 11,703 Turnover: 44,204.1900 |
3.6000Bid Size: 1,000 | 4.4800Ask Size: 559 | 60.55 mill.CHF | - | - |
Assets
2017 IFRS in mill. USD |
2018 IFRS in mill. USD |
2019 IFRS in mill. USD |
2020 IFRS in mill. USD |
2021 US GAAP in mill. USD |
|||||||
---|---|---|---|---|---|---|---|---|---|---|---|
Property and Equipment | 5 | 3.5000 | 3.3000 | 3.4000 | 4.0250 | ||||||
Intangible Assets | 26.3000 | 22.8000 | 22.6000 | 22.9000 | 20.7870 | ||||||
Long-Term Investments | .9000 | .2000 | .4000 | .4000 | .4450 | ||||||
Fixed Assets | 37.7000 | 32.2000 | 46.2000 | 46.9000 | 83.7300 | ||||||
Inventories | 2.2000 | 1.3000 | 1.1000 | 1.4000 | 4.2020 | ||||||
Accounts Receivable | 5.8000 | 6.8000 | 5.7000 | 5.9000 | 8.1300 | ||||||
Cash and Cash Equivalents | 5.7000 | 4.4000 | 6.1000 | 4.1000 | 14.8450 | ||||||
Current Assets | 27.8000 | 23.3000 | 13.6000 | 17.9000 | 45.8620 | ||||||
Total Assets | 65.5000 | 55.5000 | 59.8000 | 64.8000 | 129.5920 |
Liabilities
2017 IFRS in mill. USD |
2018 IFRS in mill. USD |
2019 IFRS in mill. USD |
2020 IFRS in mill. USD |
2021 US GAAP in mill. USD |
|||||||
---|---|---|---|---|---|---|---|---|---|---|---|
Accounts Payable | 1 | 1.1000 | 1.1000 | 1.6000 | 2.8850 | ||||||
Long-term debt | 1.5000 | - | - | - | 28.3620 | ||||||
Liabilities to Banks | 14.4000 | .9000 | 0.0000 | 2.3000 | - | ||||||
Provisions | .7000 | .5000 | .4000 | .2000 | 3.4340 | ||||||
Liabilities | 36.3000 | 17.8000 | 25.1000 | 26.9000 | 68.8290 | ||||||
Share Capital | .0300 | .0310 | .0310 | .0310 | - | ||||||
Total Equity | 29.2000 | 37.7000 | 34.7000 | 37.9000 | 56.8520 | ||||||
Minority Interests | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 3.9110 | ||||||
Total liabilities equity | 65.5000 | 55.5000 | 59.8000 | 64.8000 | 129.5920 |
Income Statement
2017 IFRS in mill. USD |
2018 IFRS in mill. USD |
2019 IFRS in mill. USD |
2020 IFRS in mill. USD |
2021 US GAAP in mill. USD |
|||||||
---|---|---|---|---|---|---|---|---|---|---|---|
Revenues | 37.4000 | 48.9000 | 41.9000 | 40.2000 | 49.5820 | ||||||
Depreciation (total) | - | - | - | - | - | ||||||
Operating Result | 4.1000 | 12 | 5.1000 | .4000 | -.4970 | ||||||
Interest Income | - | - | - | - | -12.5910 | ||||||
Income Before Taxes | 3 | 11.5000 | 4.8000 | .0800 | -13.4690 | ||||||
Income Taxes | -.6000 | -1.4000 | .9000 | -.3800 | .4550 | ||||||
Minority Interests Profit | 0.0000 | 0.0000 | 0.0000 | 0.0000 | .1860 | ||||||
Net Income | 2.4000 | 10.1000 | 5.7000 | -.3000 | -14.1100 |
Per Share
Cash Flow
2017 IFRS in mill. USD |
2018 IFRS in mill. USD |
2019 IFRS in mill. USD |
2020 IFRS in mill. USD |
2021 US GAAP in mill. USD |
|||||||
---|---|---|---|---|---|---|---|---|---|---|---|
Cash Flow from Operating Activities | 11.8000 | 12.8000 | 10.9000 | 4.7000 | .1850 | ||||||
Cash Flow from Investing Activities | -1.5000 | -.7000 | 2.5000 | -7.6000 | -40.9740 | ||||||
Cash Flow from Financing | -11.3000 | -13 | -11.9000 | .7000 | 51.0780 | ||||||
Decrease / Increase in Cash | -.2000 | -1.3000 | 1.6000 | -1.9000 | - | ||||||
Employees | - | - | - | - | - |